Supreme Court reaches compromise on breast cancer gene patent Critics of human gene patents claimed victory Thursday when the Supreme Court ruled that human genes found in nature—or isolated DNA—cannot be patented. The court also ruled that synthetic forms of DNA—complementary DNA, or cDNA—are patent eligible. The case of Association for Molecular Pathology vs. Myriad Genetics was brought by the ACLU and the Public [...]
June 13, 2013 - The Lookout via Yahoo! News
Myriad Genetics confirms Supreme Court upholds cDNA patent claims Myriad Genetics said the Supreme Court of the United States upheld its patent claims on complementary DNA, or cDNA. However, the Court ruled that five of Myriad's claims covering isolated DNA were not ...
June 13, 2013 - Theflyonthewall.com via Yahoo! Finance
Supreme Court Upholds Myriad's cDNA Patent Claims SALT LAKE CITY -- Myriad Genetics, Inc. today said the Supreme Court of the United States upheld its patent claims on complementary DNA, or cDNA. However, the Court ruled that five of Myriad's claims covering ...
June 13, 2013 - GlobeNewswire via Yahoo! Finance